Intuitive Surgical (Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where diseases are identified early and treated quickly, so patients can get back to what matters most.
Raymond James analyst Jason Bednar maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and raises the price target from $323 to $368.
Raymond James raises Intuitive Surgical (NASDAQ:ISRG) price target from $323 to $368 Read Post »
Intuitive Surgical (NASDAQ:ISRG) reported Q2 non-GAAP earnings of $1.42 per diluted share, up from $1.14 a year earlier. Analysts polled by Capital IQ expected $1.33. Revenue for the quarter ended June 30 was $1.76 billion, up from $1.52 billion a year earlier. Analysts surveyed by Capital IQ expected $1.74 billion.
Intuitive Surgical (NASDAQ:ISRG) Q2 Non-GAAP Earnings, Revenue Advance Read Post »
Citigroup analyst Joanne Wuensch maintains Intuitive Surgical (NASDAQ:ISRG) with a Buy and raises the price target from $317 to $400.
Citigroup raises Intuitive Surgical (NASDAQ:ISRG) price target from $317 to $400 Read Post »
RBC Capital analyst Shagun Singh maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and raises the price target from $309 to $355.
RBC Capital raises Intuitive Surgical (NASDAQ:ISRG) price target from $309 to $355 Read Post »
Baird analyst Mike Polark initiates coverage on Intuitive Surgical (NASDAQ:ISRG) with a Outperform rating and announces Price Target of $377.
Truist Financial analyst Richard Newitter maintains Intuitive Surgical (NASDAQ:ISRG) with a Buy and raises the price target from $347 to $400.
Bernstein analyst Lee Hambright maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and raises the price target from $350 to $365.
Bernstein raises Intuitive Surgical (NASDAQ:ISRG) price target from $350 to $365 Read Post »
Mizuho analyst Anthony Petrone maintains Intuitive Surgical (NASDAQ:ISRG) with a Neutral and raises the price target from $240 to $250.
Mizuho raised Intuitive Surgical (NASDAQ:ISRG) price target from $240 to $250 Read Post »
Raymond James analyst Jason Bednar maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and raises the price target from $270 to $323.
Raymond James raised Intuitive Surgical (NASDAQ:ISRG) price target from $270 to $323 Read Post »
Barclays Maintained Intuitive Surgical (NASDAQ:ISRG) “Overweight” rating and Raises its price target to $314.00 From $298.00.
Barclays Raised Intuitive Surgical (NASDAQ:ISRG) price target to $314.00 Read Post »
UBS analyst Danielle Antalffy initiates coverage on Intuitive Surgical (NASDAQ:ISRG) with a Neutral rating and announces Price Target of $278.
UBS announced Intuitive Surgical (NASDAQ:ISRG) Price Target of $278 Read Post »
Evercore ISI Group analyst Vijay Kumar maintains Intuitive Surgical (NASDAQ:ISRG) with a In-Line and raises the price target from $215 to $240.
Evercore ISI raises Intuitive Surgical (NASDAQ:ISRG) price target to $240 Read Post »